Literature DB >> 17080579

Fluoroquinolone-resistant Salmonella sp. in carcasses.

Yu-Chih Wang, Kuang-Sheng Yeh, Chao-Chin Chang, Shih-Ling Hsuan, Ter-Hsin Chen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17080579      PMCID: PMC3373084          DOI: 10.3201/eid1202.050629

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


× No keyword cloud information.
To the Editor: Fluoroquinolone (FQ)-resistant Salmonella has been isolated from patients in Taiwan (–). Recently, a report further indicated that several patients were infected with Salmonella enterica serovar Schwarzengrund with high-level FQ resistance (). S. Schwarzengrund has never been isolated from food animals in Taiwan. We report the isolation of FQ-resistant strains from pork and broiler carcasses sampled from 2000 to 2003: 27 in 2000, 3 in 2001, 4 in 2002, and 2 in 2003. These isolates made up 18.85% of the 191 Salmonella strains obtained from pork and broiler carcasses in the study period. Of these isolates, 16 FQ-resistant S. Schwarzengrund strains were further analyzed to elucidate the possible mechanism of FQ resistance. Ciprofloxacin MIC levels in these isolates ranged from 4 to 16 μg/mL, and all had high-level nalidixic acid resistance (>1,024 μg/mL). All of the 16 investigated strains displayed mutations possibly associated with high-level FQ resistance. The mutation sites included 2 sites (Ser83Phe and Asp87Gly) in the quinolone resistance–determining region (QRDR) of gyrA, 2 sites (Thr57Ser and Ser80Arg) in the QRDR of parC, and 1 site (Ser458Pro) in the QRDR of parE, respectively. Four strains had mutations in the QRDR of gyrA and parC only but not in the QRDR of parE (Table).
Table

Characteristics of ciprofloxacin-resistant Salmonella enterica serovar Schwarzengrund strains from carcasses*†

Strain no.Origin*Year isolatedAntimicrobial drug resistance profileQuinolone MICs (μg/mL)
Substitutions in QRDR‡
NALFLUENRCIP gyrA parC parE
A5B, M2000CmSxtTc1,024512328Ser83Phe;
Asp87GlyThr57Ser;
Ser80ArgSer458Pro
A16P, E2000ApCmNSxtTc2,048512328Ser83Phe;
Asp87GlyThr57Ser;
Ser80ArgSer458Pro
A17P, E2000ApCmNSxtTc2,0485123216Ser83Phe;
Asp87GlyThr57Ser;
Ser80ArgSer458Pro
A18P, E2000ApCmNSxtTc2,0485123216Ser83Phe;
Asp87GlyThr57Ser;
Ser80ArgSer458Pro
A19P, E2000ApCmCnNSxtTc1,024512328Ser83Phe;
Asp87GlyThr57Ser;
Ser80ArgSer458Pro
A20P, E2000ApCmNSxtTc2,048512328Ser83Phe;
Asp87GlyThr57Ser;
Ser80ArgSer458Pro
A29B, S2000CmNSxtTc1,024512328Ser83Phe;
Asp87GlyThr57Ser;
Ser80ArgSer458Pro
A36B, S2000ApCmSxtTc1,024512328Ser83Phe;
Asp87GlyThr57Ser;
Ser80ArgSer458Pro
A41P, S2000ApCmCnNSxtTc1,0245123216Ser83Phe;
Asp87GlyThr57Ser;
Ser80ArgSer458Pro
A45P, S2000ApCmNSxtTc1,0245123216Ser83Phe;
Asp87GlyThr57Ser;
Ser80Arg
A51P, S2000ApCmCnNSxtTc1,024512164Ser83Phe;
Asp87GlyThr57Ser;
Ser80Arg
A56B, M2000ApCmCnNSxtTc2,0485126416Ser83Phe;
Asp87GlyThr57Ser;
Ser80Arg
A61P, S2000CmSxtTc1,024512328Ser83Phe;
Asp87GlyThr57Ser;
Ser80ArgSer458Pro
A62P, S2000ApCmCnSxtTc2,0485126416Ser83Phe;
Asp87GlyThr57Ser;
Ser80Arg
B16P, E2001ApCmCnCroTc2,0485123216Ser83Phe;
Asp87GlyThr57Ser;
Ser80ArgSer458Pro
B73P, N2003ApCmCnNSxtTc2,0485123216Ser83Phe;
Asp87GlyThr57Ser;
Ser80ArgSer458Pro

*QRDR, quinolone resistance–determining region; B, broiler; M, middle Taiwan; P, pork; E, east Taiwan; S, south Taiwan; N, north Taiwan.
†Antimicrobial agents are ampicillin (Ap), chloramphenicol (Cm), ciprofloxacin (CIP), enrofloxacin (ENR), flumequine (FLU), gentamicin (Cn), ceftriaxone (Cro), nalidixic acid (NAL),neomycin (N), trimethoprim/sulfamethoxazole (Sxt), and tetracycline (Tc).
‡No gyrB substitutions were detected.

*QRDR, quinolone resistance–determining region; B, broiler; M, middle Taiwan; P, pork; E, east Taiwan; S, south Taiwan; N, north Taiwan.
†Antimicrobial agents are ampicillin (Ap), chloramphenicol (Cm), ciprofloxacin (CIP), enrofloxacin (ENR), flumequine (FLU), gentamicin (Cn), ceftriaxone (Cro), nalidixic acid (NAL),neomycin (N), trimethoprim/sulfamethoxazole (Sxt), and tetracycline (Tc).
‡No gyrB substitutions were detected. In conclusion, high-level FQ resistance was detected in S. Schwarzengrund isolated from pork and chicken in Taiwan. Specific mutation sites of gyrA, parC, and parE were associated with high-level FQ resistance in all the isolates investigated. Our results warrant further investigation of the public health consequences of FQ use in food animals in Taiwan.
  7 in total

1.  Prevalence and antimicrobial susceptibility of serogroup D nontyphoidal Salmonella in a university hospital in Taiwan.

Authors:  Cheng-Hsun Chiu; Lin-Hui Su; Ching-Chi Hung; Kuo-Lung Chen; Chishih Chu
Journal:  J Clin Microbiol       Date:  2004-01       Impact factor: 5.948

2.  High-level resistance to fluoroquinolones linked to mutations in gyrA, parC, and parE in Salmonella enterica serovar Schwarzengrund isolates from humans in Taiwan.

Authors:  Sylvie Baucheron; Elisabeth Chaslus-Dancla; Axel Cloeckaert; Cheng-Hsun Chiu; Patrick Butaye
Journal:  Antimicrob Agents Chemother       Date:  2005-02       Impact factor: 5.191

3.  A new therapeutic challenge for old pathogens: community-acquired invasive infections caused by ceftriaxone- and ciprofloxacin-resistant Salmonella enterica serotype choleraesuis.

Authors:  Wen-Chien Ko; Jing-Joung Yan; Wen-Liang Yu; Hsin-Chun Lee; Nan-Yao Lee; Li-Rong Wang; Yin-Ching Chuang
Journal:  Clin Infect Dis       Date:  2004-12-21       Impact factor: 9.079

4.  The emergence in Taiwan of fluoroquinolone resistance in Salmonella enterica serotype choleraesuis.

Authors:  Cheng-Hsun Chiu; Tsu-Lan Wu; Lin-Hui Su; Chishih Chu; Ju-Hsin Chia; An-Jing Kuo; Maw-Sheng Chien; Tzou-Yien Lin
Journal:  N Engl J Med       Date:  2002-02-07       Impact factor: 91.245

5.  Detection of mutations in the gyrA gene and class I integron from quinolone-resistant Salmonella enterica serovar Choleraesuis isolates in Taiwan.

Authors:  Tzu-Ming Huang; Yung-Fu Chang; Chao-Fu Chang
Journal:  Vet Microbiol       Date:  2004-06-03       Impact factor: 3.293

6.  Fluoroquinolone resistance in Salmonella enterica serotype Choleraesuis, Taiwan, 2000-2003.

Authors:  Cheng-Hsun Chiu; Tsu-Lan Wu; Lin-Hui Su; Jien-Wei Liu; Chishih Chu
Journal:  Emerg Infect Dis       Date:  2004-09       Impact factor: 6.883

7.  Ciprofloxacin-resistant Salmonella enterica Typhimurium and Choleraesuis from pigs to humans, Taiwan.

Authors:  Po-Ren Hsueh; Lee-Jene Teng; Sung-Pin Tseng; Chao-Fu Chang; Jen-Hsien Wan; Jing-Jou Yan; Chun-Ming Lee; Yin-Ching Chuang; Wen-Kuei Huang; Dine Yang; Jainn-Ming Shyr; Kwok-Woon Yu; Li-Shin Wang; Jang-Jih Lu; Wen-Chien Ko; Jiunn-Jong Wu; Feng-Yee Chang; Yi-Chueh Yang; Yeu-Jun Lau; Yung-Ching Liu; Cheng-Yi Liu; Shen-Wu Ho; Kwen-Tay Luh
Journal:  Emerg Infect Dis       Date:  2004-01       Impact factor: 6.883

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.